Oxalatoplatinum
Categoria
Oxalatoplatinum Nombres de marca, Oxalatoplatinum Analogos
Oxalatoplatinum Marca los nombres de mezcla
Oxalatoplatinum Formula quimica
Oxalatoplatinum RX enlace
Oxalatoplatinum FDA hoja
Oxalatoplatinum MSDS (hoja de seguridad de materiales)
Oxalatoplatinum Sintesis de referencia
Oxalatoplatinum Peso molecular
Oxalatoplatinum Punto de fusion
Oxalatoplatinum H2O Solubilidad
Oxalatoplatinum Estado
Oxalatoplatinum LogP
Oxalatoplatinum Formas de dosificacion
Oxalatoplatinum Indicacion
Oxalatoplatinum Farmacologia
Oxalatoplatinum Absorcion
Oxalatoplatinum Toxicidad
Oxalatoplatinum Informacion de Pacientes
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
